Eurazeo Management

Management criteria checks 3/4

Eurazeo's CEO is Christophe Baviere, appointed in Mar 2021, has a tenure of 2.83 years. total yearly compensation is €1.79M, comprised of 31% salary and 69% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth $12.47M. The average tenure of the management team and the board of directors is 2.8 years and 8.7 years respectively.

Key information

Christophe Baviere

Chief executive officer

€1.8m

Total compensation

CEO salary percentage	31.0%
CEO tenure	2.8yrs
CEO ownership	0.2%
Management average tenure	2.8yrs
Board average tenure	8.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Christophe Baviere's remuneration changed compared to Eurazeo's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2023	n/a	n/a	€2b
Mar 31 2023	n/a	n/a	€2b
Dec 31 2022	€2m	€555k	€595m
Sep 30 2022	n/a	n/a	€801m
Jun 30 2022	n/a	n/a	€1b
Mar 31 2022	n/a	n/a	€1b
Dec 31 2021	€1m	€487k	€2b

Compensation vs Market: Christophe's total compensation ($USD1.96M) is below average for companies of similar size in the US market ($USD7.65M).

Compensation vs Earnings: Christophe's compensation has increased by more than 20% in the past year.

CEO

Christophe Baviere (59 yo)

2.8yrs

Tenure

€1,791,427

Compensation

Mr. Christophe M. Baviere serves as Co-Chief Executive Officer at Eurazeo North America, Inc He is Chairman of the Executive Board & Co-CEO of Eurazeo SE from 2023. He was Chairman of the Executive Board,...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Christophe Baviere	Chairman of the Executive Board & Co-CEO	2.8yrs	€1.79m	0.21% $ 12.5m
William Kadouch-Chassaing	Co-CEO, GD Finance and Strategy	1.8yrs	€1.68m	no data
Olivier Millet	Member of the Executive Board and Managing Partner of Small-mid buyout & NovSanté	5.8yrs	€1.62m	0.073% $ 4.3m
Laurence Branthomme	Chief Financial Officer & Head of Operations	less than a year	no data	no data
Sophie Flak	Member of Executive Board	less than a year	no data	no data
Arnaud Berthe	Managing Director of Group Accounting	no data	no data	no data
Valérie Ducourty	Managing Director of Corporate Financing	no data	no data	no data
Jean-Daniel Vouille	Chief Technical Officer	no data	no data	no data
Pierre Bernardin	Director & Head of Investor Relations	4.3yrs	no data	no data
Sylviane Guyonnet	Deputy CEO of EIM & Group Head of Compliance	no data	no data	no data
Florine Letort	Legal & Compliance Manager	no data	no data	no data
Laurent Guerineau	Managing Director of Direct Transactions - Investment Partners	7.3yrs	no data	no data

2.8yrs

Average Tenure

54yo

Average Age

Experienced Management: EUZO.F's management team is considered experienced (2.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Vivianne Akriche	Employee Representative Member of the Supervisory Board & Managing Director of Mid-large buyout	4.9yrs	no data	0.010% $ 598.2k
Christophe Aubut	Tax Structuring Director & Employee Representative Member of Supervisory Board	8.1yrs	no data	0.018% $ 1.0m
Bruno Roger	Honorary Chairman of the Supervisory Board	no data	no data	no data
Jean-Pierre Richardson	Non-Voting Board Member	15.7yrs	€66.14k	0.0023% $ 132.3k
Jean-Charles Decaux	Chairman of the Supervisory Board	6.6yrs	€193.33k	0.0011% $ 65.0k
Victoire de Margerie	Independent Member of Supervisory Board	11.7yrs	€47.00k	0.0011% $ 62.6k
Stephane Pallez	Independent Member of the Supervisory Board	10.7yrs	€78.25k	0.0022% $ 130.5k
Olivier du Vignaux	Vice Chairman of Supervisory Board	19.7yrs	€103.00k	0.0012% $ 67.9k
Roland du de Montsaulnin	Member of Supervisory Board	19.7yrs	€55.00k	0.0028% $ 164.5k
Emmanuel Russel	Member of Supervisory Board	6.6yrs	€103.14k	no data
Françoise Mercadal-Delasalles	Independent Member of the Supervisory Board	8.7yrs	€102.00k	0.0010% $ 61.5k
Amelie Oudea-Castera	Independent Member of the Supervisory Board	5.8yrs	€19.25k	no data

8.7yrs

Average Tenure

60.5yo

Average Age

Experienced Board: EUZO.F's board of directors are considered experienced (8.7 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/01/09 12:56
End of Day Share Price	2023/10/12 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eurazeo SE is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Pierre-Yves Gauthier	AlphaValue
Christoph Greulich	Berenberg
Nicolas Vaysselier	BNP Paribas Exane

Eurazeo Management

Management criteria checks 3/4

Key information

Recent management updates

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Eurazeo Appoints Sophie Flak to Its Executive Committee

Recent updates

A consortium led by Financière de Blacailloux SAS entered into exclusive discussions to acquire 70% stake in Albingia Compagnie D'Assurance from Eurazeo SE (ENXTPA:RF).

Wrike, Inc. signed an agreement to acquire Klaxoon SAS from Sofiouest SA, Eurazeo SE (ENXTPA:RF) and Bpifrance Investissement SAS.

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Eurazeo SE Announces Its Intention to Resume Distribution

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

Croda International Plc (LSE:CRDA) completed the acquisition of Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others.

Croda International Plc (LSE:CRDA) agreed to acquire Iberchem S.A. from Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF) and others for €820 million.

Hippocrates Holding Draws Up Shortlist of Four for Italy Pharmacy Network

Eurazeo Seeks to Buy Questel

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Volkswagen AG has entered into an agreement to sell Europcar International SA to Eurazeo SA for €3.32 billion.

Eurazeo Appoints Sophie Flak to Its Executive Committee

Eurazeo Reportedly in Negotiations to Take Majority Stake in EasyVista

Eurazeo SE (ENXTPA:RF) entered into an agreement to acquire of remaining 20% stake in Idinvest Partners SA from Christophe Bavière, Benoist Grossmann and their partners.

Eurazeo SE (ENXTPA:RF) completed the acquisition of 25% stake in MCH.

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources